Fortress Biotech (FBIO) Revenue Growth (3y) (2018 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Revenue Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 77.85% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -25.02% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 42.02% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 59.40% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 7.80% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 76.62% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 2.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49% |
| Dec 31, 2025 | -0.66% |
| Sep 30, 2025 | 2.18% |
| Jun 30, 2025 | -3.45% |
| Mar 31, 2025 | -18.11% |
| Dec 31, 2024 | -6.12% |
| Sep 30, 2024 | -11.47% |
| Jun 30, 2024 | -5.84% |
| Mar 31, 2024 | 3.99% |
| Dec 31, 2023 | 13.20% |
| Sep 30, 2023 | 54.22% |
| Jun 30, 2023 | 22.50% |
| Mar 31, 2023 | -1.28% |
| Dec 31, 2022 | 13.80% |
| Sep 30, 2022 | 19.15% |
| Jun 30, 2022 | 25.39% |
| Mar 31, 2022 | 54.58% |
| Dec 31, 2021 | 26.68% |
| Sep 30, 2021 | 59.74% |
| Jun 30, 2021 | 37.83% |